Market Overview:
The global nuclear fast red staining solution market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for research and diagnostic laboratories, rising number of hospital admissions, and growing awareness about diagnostic procedures. Based on type, the global nuclear fast red staining solution market is segmented into solution and powder. The powder segment is expected to grow at a higher CAGR than the solution segment during the forecast period from 2018 to 2030. This can be attributed to its properties such as easy handling and storage, non-toxicity, and low cost as compared with other types of stains available in the market. Based on application, the global nuclear fast red staining solution market is divided into research laboratory, hospital laboratory, and others (including veterinary laboratories). The research laboratory segment dominates this market owing to an increase in R&D spending by pharmaceutical companies across different geographies coupled with rising number of contract research organizations (CROs) globally.
Product Definition:
A nuclear fast red staining solution is a type of dye that is used to stain cells in order to make them more visible. This type of dye is often used to visualize the nucleus of a cell, which can be important for studying the structure and function of cells.
Solution:
Solution is a chemical compound or a mixture of compounds, which when added to an aqueous medium reacts with the target substance to produce the desired color. Solutions are used in various end-use industries such as food & beverages, pharmaceuticals and cosmetics among others. Nuclear fast red staining solution is one of the widely used solutions for hematoxylin and eosin (H&E) staining in medical sciences.
Powder:
Powder is a dry solid material that can be used to color any liquid or solution. It consists of fine and large particles which are evenly distributed in the powder. The most commonly used powders for staining include those made up of calcium carbonate, chromium oxide, potassium dichromate, and ferric chloride among others.
Application Insights:
The research laboratory application segment led the global market in 2017. The use of nuclear fast red for staining cell nuclei is a well-established practice in various research laboratories across the world. It has been used to stain a wide range of cells including bacteria, viruses, and eukaryotic cells such as fungi and roundworms. In addition, it is also used for staining plant tissues and animal tissues that have been fixed with formalin or embedding mediums respectively.
Hospital application was the second largest segment in 2017 owing to rising demand from endocrinology departments for tissue stains during surgeries or medical procedures involving hormones or anatomy related to endocrine system. Nuclear Fast Red Stain Kit plays an important role in clinical pathology tests which are conducted frequently before major surgeries by pathologists at hospitals around the world. These kits help enhance visibility of certain structures on routine clinical samples thereby aiding accurate diagnosis at minimal costs compared with other methods available in the market place today (2017).
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of nuclear medicine facilities coupled with high adoption rate for advanced diagnostic techniques is one of the major factors responsible for its dominance. In addition, increasing R&D activities by various companies to develop new and innovative products is also expected to drive growth over the forecast period.
Asia Pacific region is anticipated to witness lucrative growth over the forecast period owing to rising healthcare spending and improving infrastructure in countries such as China, India, South Korea, Singapore and Japan. Moreover, growing awareness regarding nuclear medicine procedures along with an increase in outsourcing opportunities are some other factors driving regional demand. ‘Global Nuclear Fast Red Staining Solution Market Size And Share & Trends Analysis Report By Application (Research Laboratory), And Region (North America, Europe), 2018 - 2030' can be downloaded from here.
Growth Factors:
- Increasing demand for fast, accurate, and reliable diagnostic tests
- Growing number of research studies on the use of nuclear fast red staining solution in various applications
- Rising prevalence of cancer and other diseases that require diagnosis using nuclear fast red staining solution
- Technological advancements in the field of immunohistochemistry that are making nuclear fast red staining solution more efficient and accurate
- Growing awareness about the benefits of using nuclear fast red staining solution in diagnostic tests
Scope Of The Report
Report Attributes
Report Details
Report Title
Nuclear Fast Red Staining Solution Market Research Report
By Type
Solution, Powder
By Application
Research Laboratory, Hospital, Others
By Companies
Abcam Plc., Avantor, Inc., BioGnost, Electron Microscopy Sciences, Geno Technology, Inc., Merck., Thermo Fisher Scientific, Tokyo Chemical Industry Co., Ltd., Boster Biological Technology Co.Ltd
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
197
Number of Tables & Figures
138
Customization Available
Yes, the report can be customized as per your need.
Global Nuclear Fast Red Staining Solution Market Report Segments:
The global Nuclear Fast Red Staining Solution market is segmented on the basis of:
Types
Solution, Powder
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research Laboratory, Hospital, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abcam Plc.
- Avantor, Inc.
- BioGnost
- Electron Microscopy Sciences
- Geno Technology, Inc.
- Merck.
- Thermo Fisher Scientific
- Tokyo Chemical Industry Co., Ltd.
- Boster Biological Technology Co.Ltd
Highlights of The Nuclear Fast Red Staining Solution Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Solution
- Powder
- By Application:
- Research Laboratory
- Hospital
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Nuclear Fast Red Staining Solution Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Nuclear Fast Red Staining Solution is a stain that uses the nuclear reaction of uranium to produce a red color.
Some of the major players in the nuclear fast red staining solution market are Abcam Plc., Avantor, Inc., BioGnost, Electron Microscopy Sciences, Geno Technology, Inc., Merck., Thermo Fisher Scientific, Tokyo Chemical Industry Co., Ltd., Boster Biological Technology Co.Ltd.
The nuclear fast red staining solution market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Nuclear Fast Red Staining Solution Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Nuclear Fast Red Staining Solution Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Nuclear Fast Red Staining Solution Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Nuclear Fast Red Staining Solution Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Nuclear Fast Red Staining Solution Market Size & Forecast, 2020-2028
4.5.1 Nuclear Fast Red Staining Solution Market Size and Y-o-Y Growth
4.5.2 Nuclear Fast Red Staining Solution Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Solution
5.2.2 Powder
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Research Laboratory
6.2.2 Hospital
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Nuclear Fast Red Staining Solution Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Nuclear Fast Red Staining Solution Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Solution
9.6.2 Powder
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Research Laboratory
9.10.2 Hospital
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Solution
10.6.2 Powder
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Research Laboratory
10.10.2 Hospital
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Solution
11.6.2 Powder
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Research Laboratory
11.10.2 Hospital
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Solution
12.6.2 Powder
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Research Laboratory
12.10.2 Hospital
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Solution
13.6.2 Powder
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Research Laboratory
13.10.2 Hospital
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Nuclear Fast Red Staining Solution Market: Competitive Dashboard
14.2 Global Nuclear Fast Red Staining Solution Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abcam Plc.
14.3.2 Avantor, Inc.
14.3.3 BioGnost
14.3.4 Electron Microscopy Sciences
14.3.5 Geno Technology, Inc.
14.3.6 Merck.
14.3.7 Thermo Fisher Scientific
14.3.8 Tokyo Chemical Industry Co., Ltd.
14.3.9 Boster Biological Technology Co.Ltd
